InterCure Ltd. (TLV:INCR)
Israel
· Delayed Price · Currency is ILS · Price in ILA 554.00
-11.50 (-2.03%)
May 13, 2025, 5:24 PM IDT
InterCure Revenue
In the year 2024, InterCure had annual revenue of 238.85M ILS, down -32.82%. InterCure had revenue of 113.11M in the half year ending December 31, 2024, a decrease of -45.14%.
Revenue
238.85M
Revenue Growth
-32.82%
P/S Ratio
1.12
Revenue / Employee
746.39K
Employees
320
Market Cap
266.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 238.85M | -116.71M | -32.82% |
| Dec 31, 2023 | 355.55M | -33.13M | -8.52% |
| Dec 31, 2022 | 388.68M | 169.01M | 76.93% |
| Dec 31, 2021 | 219.68M | 154.64M | 237.78% |
| Dec 31, 2020 | 65.04M | 56.11M | 628.60% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 61.87B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 586.24M |
| Bait Bakfar | 103.40M |
| Novolog (Pharm-Up 1966) | 2.02B |
| SofWave Medical | 235.09M |
| Ilex Medical | 920.37M |
| BrainsWay | 149.39M |